Filtered By:
Specialty: Urology & Nephrology
Therapy: Neoadjuvant Chemotherapy Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 335 results found since Jan 2013.

Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods —what’s around the corner?
ConclusionCurrent diagnostic methods for UTUC have shortcomings, especially concerning prognostication, which is important for personalized treatment decisions. There are several upcoming methods that may be of interest for UTUC. Most have been studied for urothelial carcinoma of the bladder, and it is important to keep in mind that UTUC is a different entity and not all methods are adaptable or applicable to UTUC.
Source: World Journal of Urology - September 19, 2023 Category: Urology & Nephrology Source Type: research

Sequential Chemotherapy Followed by Radiotherapy Versus Concurrent Chemo-Radiation in Muscle Invasive Bladder Cancer
Urol J. 2023 Jul 31. doi: 10.22037/uj.v20i.7525. Online ahead of print.ABSTRACTBladder cancer is diagnosed at older age compared to all other known cancer types. Radical cystectomy after neoadjuvant chemotherapy or tri-modality treatment (consist of TURB, concurrent chemo-radiation) are the standard treatments. Many of the patients cannot receive tri-modality treatment (concurrent chemo-radiation) because of medical comorbidities. The present study assessed the results of sequential use of chemotherapy and radiotherapy versus concurrent use of them in 266 muscle invasive bladder cancer patients. The results showed similar ...
Source: Urology Journal - September 5, 2023 Category: Urology & Nephrology Authors: Mohammad Hasan Larizadeh Fateme Arabnejad Mohammad Reza Ebadzadeh Source Type: research

The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location
CONCLUSION: NAC-GC improves both pathological outcomes and oncological prognosis in patients with cT3N0M0 UTUC. With regard to tumor location, RPT has better pathological outcomes and oncological prognoses than UT.PMID:37634073
Source: Urology Journal - August 27, 2023 Category: Urology & Nephrology Authors: Yuki Kohada Tetsutaro Hayashi Kenshiro Takemoto Syunsuke Miyamoto Takashi Babasaki Kohei Kobatake Hiroyuki Kitano Kenichiro Ikeda Keisuke Goto Keisuke Hieda Yukiko Honda Kazuhiro Sentani Naohide Oue Kazuo Awai Nobuyuki Hinata Source Type: research